Watermark

BGB-3111-212

Completed

A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-212

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2017

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20220712

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan